{"gene":"PF3D7_1460400","run_date":"2026-09-08T14:19:07","timeline":{"discoveries":[{"year":2007,"finding":"PfUCHL3 (PF3D7_1460400) possesses both deubiquitinating and deNeddylating (deNedd8) enzymatic activity, as demonstrated using an activity-based chemical probe that covalently labels ubiquitin hydrolases.","method":"Activity-based chemical probe (covalent labeling) and mass spectrometry; enzyme activity assays","journal":"Cellular microbiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct enzymatic activity assay with activity-based probe on the recombinant enzyme, replicated across two apicomplexan species in the same study","pmids":["17371404"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"finding":"PfUCHL3 uses an active site crossover loop to restrict access of bulky ubiquitin adducts (including ubiquitin chains of various linkages) to the active site; the physical integrity of this loop is dispensable for catalysis itself, but enlarging it via gain-of-function mutations enables cleavage of substrates the wild-type enzyme cannot process.","method":"Sortagging (protein cleavage/tagging technique), active site crossover loop mutagenesis, in vitro enzyme activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay combined with mutagenesis of the active site in a single rigorous study","pmids":["19047059"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Crystal structures of PfUCHL3 alone and in complex with the ubiquitin-based suicide substrate UbVME reveal a rigid active site crossover loop that restricts substrate size; molecular dynamics simulations of PfUCHL3–PfNedd8 complex identified shared key interactions explaining dual specificity for ubiquitin and Nedd8; PfUCHL3 is essential to parasite survival.","method":"X-ray crystallography (PfUCHL3 apo and PfUCHL3–UbVME complex), molecular dynamics simulation, genetic evidence of essentiality","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures with bound suicide substrate plus MD simulation plus functional essentiality evidence, all in one study","pmids":["20042598"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2022,"finding":"Inhibition of PfUCHL3 enzymatic activity by two compounds (MMV676603 and MMV688704) causes accumulation of polyubiquitinated substrates and disrupts parasite phenotype at late asexual stages, consistent with PfUCHL3 being essential to parasite survival and functioning in ubiquitin removal from substrates in blood-stage parasites.","method":"In vitro enzyme inhibition assay, anti-plasmodial growth assay, immunofluorescence/phenotypic analysis, cytotoxicity assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzymatic inhibition combined with cellular phenotype (polyubiquitin accumulation) and parasite growth, single lab","pmids":["35042884"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"finding":"Covalent fragment inhibitors selective for PfUCHL3 over human UCHL3 and UCHL1 inhibit asexual P. falciparum blood-stage growth and P. berghei sporozoite stages, demonstrating that PfUCHL3 enzymatic activity is required across multiple parasite developmental stages.","method":"High-throughput covalent fragment screen, in vitro enzyme inhibition assay, parasite growth inhibition assay (P. falciparum blood stages; P. berghei sporozoites), cytotoxicity assay","journal":"Bioorganic & medicinal chemistry letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — selective enzymatic inhibition combined with multi-stage parasite phenotype, single lab","pmids":["37634761"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":""}]},{"year":2024,"finding":"Chemically constrained peptides identified by RaPID mRNA display bind PfUCHL3 with nanomolar affinity and selectively inhibit its deubiquitinase activity; NMR spectroscopy showed these peptides do not bind the active site but instead block the ubiquitin substrate-binding interface, revealing an allosteric or exosite-based mechanism of inhibition.","method":"RaPID mRNA display (in vitro selection), fluorescence polarization/affinity measurement, in vitro deubiquitinase activity assay, NMR spectroscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure mapping plus in vitro enzymatic inhibition assay plus affinity measurement, orthogonal methods in a single rigorous study","pmids":["38739798"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2024,"finding":"PfUCHL3 is a direct molecular target of halofuginone (HF) in P. falciparum; HF forms hydrogen bonds with residues Leu10, Glu11, and Arg217 of PfUCHL3, induces an allosteric effect promoting embedding of the helix 6' surface region, and disrupts PfUCHL3-mediated expression of multiple proteins involved in amino acid biosynthesis and metabolism.","method":"Chemoproteomic photoaffinity labeling probe of halofuginone, target identification in parasite lysate, molecular docking/structural analysis, proteomics","journal":"Chembiochem : a European journal of chemical biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — photoaffinity labeling identifies PfUCHL3 as direct target, single lab, mechanistic binding details from docking (not high-resolution structure)","pmids":["38923255"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"PF3D7_1460400 (PfUCHL3) is an essential deubiquitinase and deNeddylase in P. falciparum that uses a rigid active site crossover loop to restrict substrate size; crystal structures with a ubiquitin-based suicide substrate revealed the structural basis of dual ubiquitin/Nedd8 specificity, while NMR and mutagenesis studies showed that inhibitory peptides block the ubiquitin-substrate–binding interface rather than the catalytic site, and pharmacological inhibition of its enzymatic activity causes accumulation of polyubiquitinated proteins and kills parasites across multiple life-cycle stages."},"narrative":{"mechanistic_narrative":"PF3D7_1460400 (UCHL3) is an essential ubiquitin C-terminal hydrolase of Plasmodium falciparum that acts as a dual deubiquitinase and deNeddylase, removing both ubiquitin and Nedd8 modifications from substrates [PMID:17371404, PMID:20042598]. Its catalytic behavior is governed by an active-site crossover loop that sterically restricts access of bulky adducts to the catalytic center; the loop is dispensable for catalysis per se, but enlarging it by mutation permits cleavage of substrates the wild-type enzyme cannot process, defining a size-restriction mechanism [PMID:19047059]. Crystal structures of the apo enzyme and of a complex with the ubiquitin-based suicide substrate UbVME, together with modeling of the enzyme–Nedd8 complex, reveal the rigid crossover loop and the shared interactions that underlie dual ubiquitin/Nedd8 specificity, and the enzyme is essential for parasite survival [PMID:20042598]. Functionally, inhibition of UCHL3 catalytic activity causes accumulation of polyubiquitinated proteins and disrupts blood-stage parasites, consistent with a role in ubiquitin removal from substrates [PMID:35042884], and its activity is required across multiple developmental stages including P. falciparum asexual blood stages and P. berghei sporozoites [PMID:37634761]. The enzyme is druggable through distinct modalities: covalent fragments selective over human UCHL3/UCHL1 [PMID:37634761], constrained peptides that block the ubiquitin substrate-binding interface rather than the active site [PMID:38739798], and halofuginone, which binds UCHL3 directly and disrupts its influence on amino-acid biosynthetic protein expression [PMID:38923255]. Beyond these findings, endogenous physiological substrates of UCHL3 in the parasite have not been defined in the available corpus.","teleology":[{"year":2007,"claim":"Establishing that the parasite enzyme is enzymatically active answered whether PF3D7_1460400 is a functional hydrolase and revealed it acts on two distinct ubiquitin-like modifiers.","evidence":"Activity-based covalent chemical probe and mass spectrometry on the recombinant enzyme","pmids":["17371404"],"confidence":"High","gaps":["No endogenous substrates identified","Relative preference for ubiquitin versus Nedd8 not quantified","Cellular role not yet tested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"claim":"Mutagenesis of the active-site crossover loop resolved how the enzyme selects substrates, showing that steric restriction by the loop—not the catalytic machinery—limits which adducts can be cleaved.","evidence":"Sortagging, crossover-loop mutagenesis, and in vitro activity assays","pmids":["19047059"],"confidence":"High","gaps":["Physiological consequence of size restriction unknown","Which native ubiquitin chain linkages are handled in vivo unclear"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Crystallographic capture of the enzyme with a suicide substrate provided the structural basis for both dual ubiquitin/Nedd8 specificity and substrate-size restriction, and genetic evidence established the gene as essential.","evidence":"X-ray structures (apo and UbVME complex), molecular dynamics of the enzyme–Nedd8 complex, and essentiality data","pmids":["20042598"],"confidence":"High","gaps":["No experimental structure of the enzyme–Nedd8 complex","Essentiality mechanism (which pathway failure kills the parasite) undefined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2022,"claim":"Small-molecule inhibition linked the enzyme's catalytic activity to a cellular phenotype, showing that blocking it causes polyubiquitin accumulation and disrupts late asexual blood-stage parasites.","evidence":"In vitro enzyme inhibition with two compounds, anti-plasmodial growth assay, and immunofluorescence phenotyping","pmids":["35042884"],"confidence":"Medium","gaps":["Single lab","Off-target contributions to the growth phenotype not excluded","Specific accumulating substrates not identified"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"claim":"Selective covalent fragments demonstrated that the enzyme's activity is required across life-cycle stages, extending its essentiality beyond blood stages to transmission-relevant sporozoites.","evidence":"Covalent fragment screen, selective enzyme inhibition over human orthologs, and growth assays in P. falciparum blood stages and P. berghei sporozoites","pmids":["37634761"],"confidence":"Medium","gaps":["Single lab","In-parasite target engagement not directly confirmed","Stage-specific substrates unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":""}]},{"year":2024,"claim":"Two orthogonal chemical-biology studies defined druggable surfaces beyond the catalytic site—an exosite at the ubiquitin substrate-binding interface and a halofuginone-binding pocket—clarifying how the enzyme can be inhibited allosterically.","evidence":"RaPID mRNA display peptides with NMR mapping and deubiquitinase assays [#5]; halofuginone photoaffinity chemoproteomics with docking and proteomics [#6]","pmids":["38739798","38923255"],"confidence":"Medium","gaps":["Halofuginone binding modeled by docking, not high-resolution structure","Direct causal link between the amino-acid metabolism proteome change and enzyme activity not established","Physiological substrates whose deubiquitination is blocked remain unidentified"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The endogenous ubiquitin/Nedd8 substrates and the specific cellular pathway whose disruption makes the enzyme essential remain undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No physiological substrate identified","Relationship between deubiquitinase and deNeddylase functions in vivo unresolved","Interactome/complex membership uncharacterized"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":[],"other_free_text":["Dual deubiquitinase/deNeddylase specificity is structurally explained by shared active-site interactions with ubiquitin and Nedd8 [#0, #2]","An active-site crossover loop imposes substrate-size restriction; enlarging it enables cleavage of otherwise-refractory substrates [#1]","Essential for parasite survival across asexual blood stages (P. falciparum) and sporozoite stages (P. berghei) [#2, #3, #4]","Inhibition causes accumulation of polyubiquitinated proteins in blood-stage parasites [#3]","Druggable via covalent fragments selective over human UCHL3/UCHL1 [#4], exosite-binding constrained peptides that block the ubiquitin substrate interface [#5], and direct halofuginone binding [#6]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"17371404","id":"PMC_17371404","title":"Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution.","date":"2007","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17371404","citation_count":78,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["UCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19047059","id":"PMC_19047059","title":"Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19047059","citation_count":54,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["UCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20042598","id":"PMC_20042598","title":"Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20042598","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["UCHL3","PfUCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31658303","id":"PMC_31658303","title":"Nedd8 hydrolysis by UCH proteases in Plasmodium parasites.","date":"2019","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/31658303","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35042884","id":"PMC_35042884","title":"Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activity.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35042884","citation_count":10,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfUCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"37634761","id":"PMC_37634761","title":"Identification of covalent fragment inhibitors for Plasmodium falciparum UCHL3 with anti-malarial efficacy.","date":"2023","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/37634761","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["UCHL3","PfUCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23708419","id":"PMC_23708419","title":"A structural comparative approach to identifying novel antimalarial inhibitors.","date":"2013","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23708419","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["UCHL3","PfUCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38739798","id":"PMC_38739798","title":"Targeting the Plasmodium falciparum UCHL3 ubiquitin hydrolase using chemically constrained peptides.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38739798","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["UCHL3","PfUCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38923255","id":"PMC_38923255","title":"Chemoproteomic Strategy Identifies PfUCHL3 as the Target of Halofuginone.","date":"2024","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/38923255","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfUCHL3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24533266","id":"PMC_24533266","title":"The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention?","date":"2012","source":"International journal for parasitology. Drugs and drug resistance","url":"https://pubmed.ncbi.nlm.nih.gov/24533266","citation_count":64,"is_preprint":false,"source_species":["Pf"],"role":"citation_expansion","match_terms":["fwd_cite"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33022940","id":"PMC_33022940","title":"Ubiquitin-Like Modifiers: Emerging Regulators of Protozoan Parasites.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33022940","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"citation_expansion","match_terms":["fwd_cite"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38892332","id":"PMC_38892332","title":"Post-Translational Modifications of Proteins of Malaria Parasites during the Life Cycle.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38892332","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"citation_expansion","match_terms":["fwd_cite"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7687,"output_tokens":2046,"usd":0.026876,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7374,"output_tokens":2995,"usd":0.055872,"stage2_stop_reason":"end_turn"},"total_usd":0.082748,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"PfUCHL3 (PF3D7_1460400) possesses both deubiquitinating and deNeddylating (deNedd8) enzymatic activity, as demonstrated using an activity-based chemical probe that covalently labels ubiquitin hydrolases.\",\n      \"method\": \"Activity-based chemical probe (covalent labeling) and mass spectrometry; enzyme activity assays\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct enzymatic activity assay with activity-based probe on the recombinant enzyme, replicated across two apicomplexan species in the same study\",\n      \"pmids\": [\"17371404\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PfUCHL3 uses an active site crossover loop to restrict access of bulky ubiquitin adducts (including ubiquitin chains of various linkages) to the active site; the physical integrity of this loop is dispensable for catalysis itself, but enlarging it via gain-of-function mutations enables cleavage of substrates the wild-type enzyme cannot process.\",\n      \"method\": \"Sortagging (protein cleavage/tagging technique), active site crossover loop mutagenesis, in vitro enzyme activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay combined with mutagenesis of the active site in a single rigorous study\",\n      \"pmids\": [\"19047059\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of PfUCHL3 alone and in complex with the ubiquitin-based suicide substrate UbVME reveal a rigid active site crossover loop that restricts substrate size; molecular dynamics simulations of PfUCHL3–PfNedd8 complex identified shared key interactions explaining dual specificity for ubiquitin and Nedd8; PfUCHL3 is essential to parasite survival.\",\n      \"method\": \"X-ray crystallography (PfUCHL3 apo and PfUCHL3–UbVME complex), molecular dynamics simulation, genetic evidence of essentiality\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures with bound suicide substrate plus MD simulation plus functional essentiality evidence, all in one study\",\n      \"pmids\": [\"20042598\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Inhibition of PfUCHL3 enzymatic activity by two compounds (MMV676603 and MMV688704) causes accumulation of polyubiquitinated substrates and disrupts parasite phenotype at late asexual stages, consistent with PfUCHL3 being essential to parasite survival and functioning in ubiquitin removal from substrates in blood-stage parasites.\",\n      \"method\": \"In vitro enzyme inhibition assay, anti-plasmodial growth assay, immunofluorescence/phenotypic analysis, cytotoxicity assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzymatic inhibition combined with cellular phenotype (polyubiquitin accumulation) and parasite growth, single lab\",\n      \"pmids\": [\"35042884\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Covalent fragment inhibitors selective for PfUCHL3 over human UCHL3 and UCHL1 inhibit asexual P. falciparum blood-stage growth and P. berghei sporozoite stages, demonstrating that PfUCHL3 enzymatic activity is required across multiple parasite developmental stages.\",\n      \"method\": \"High-throughput covalent fragment screen, in vitro enzyme inhibition assay, parasite growth inhibition assay (P. falciparum blood stages; P. berghei sporozoites), cytotoxicity assay\",\n      \"journal\": \"Bioorganic & medicinal chemistry letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective enzymatic inhibition combined with multi-stage parasite phenotype, single lab\",\n      \"pmids\": [\"37634761\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium berghei\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Chemically constrained peptides identified by RaPID mRNA display bind PfUCHL3 with nanomolar affinity and selectively inhibit its deubiquitinase activity; NMR spectroscopy showed these peptides do not bind the active site but instead block the ubiquitin substrate-binding interface, revealing an allosteric or exosite-based mechanism of inhibition.\",\n      \"method\": \"RaPID mRNA display (in vitro selection), fluorescence polarization/affinity measurement, in vitro deubiquitinase activity assay, NMR spectroscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure mapping plus in vitro enzymatic inhibition assay plus affinity measurement, orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"38739798\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PfUCHL3 is a direct molecular target of halofuginone (HF) in P. falciparum; HF forms hydrogen bonds with residues Leu10, Glu11, and Arg217 of PfUCHL3, induces an allosteric effect promoting embedding of the helix 6' surface region, and disrupts PfUCHL3-mediated expression of multiple proteins involved in amino acid biosynthesis and metabolism.\",\n      \"method\": \"Chemoproteomic photoaffinity labeling probe of halofuginone, target identification in parasite lysate, molecular docking/structural analysis, proteomics\",\n      \"journal\": \"Chembiochem : a European journal of chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — photoaffinity labeling identifies PfUCHL3 as direct target, single lab, mechanistic binding details from docking (not high-resolution structure)\",\n      \"pmids\": [\"38923255\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"PF3D7_1460400 (PfUCHL3) is an essential deubiquitinase and deNeddylase in P. falciparum that uses a rigid active site crossover loop to restrict substrate size; crystal structures with a ubiquitin-based suicide substrate revealed the structural basis of dual ubiquitin/Nedd8 specificity, while NMR and mutagenesis studies showed that inhibitory peptides block the ubiquitin-substrate–binding interface rather than the catalytic site, and pharmacological inhibition of its enzymatic activity causes accumulation of polyubiquitinated proteins and kills parasites across multiple life-cycle stages.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PF3D7_1460400 (UCHL3) is an essential ubiquitin C-terminal hydrolase of Plasmodium falciparum that acts as a dual deubiquitinase and deNeddylase, removing both ubiquitin and Nedd8 modifications from substrates [#0, #2]. Its catalytic behavior is governed by an active-site crossover loop that sterically restricts access of bulky adducts to the catalytic center; the loop is dispensable for catalysis per se, but enlarging it by mutation permits cleavage of substrates the wild-type enzyme cannot process, defining a size-restriction mechanism [#1]. Crystal structures of the apo enzyme and of a complex with the ubiquitin-based suicide substrate UbVME, together with modeling of the enzyme–Nedd8 complex, reveal the rigid crossover loop and the shared interactions that underlie dual ubiquitin/Nedd8 specificity, and the enzyme is essential for parasite survival [#2]. Functionally, inhibition of UCHL3 catalytic activity causes accumulation of polyubiquitinated proteins and disrupts blood-stage parasites, consistent with a role in ubiquitin removal from substrates [#3], and its activity is required across multiple developmental stages including P. falciparum asexual blood stages and P. berghei sporozoites [#4]. The enzyme is druggable through distinct modalities: covalent fragments selective over human UCHL3/UCHL1 [#4], constrained peptides that block the ubiquitin substrate-binding interface rather than the active site [#5], and halofuginone, which binds UCHL3 directly and disrupts its influence on amino-acid biosynthetic protein expression [#6]. Beyond these findings, endogenous physiological substrates of UCHL3 in the parasite have not been defined in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing that the parasite enzyme is enzymatically active answered whether PF3D7_1460400 is a functional hydrolase and revealed it acts on two distinct ubiquitin-like modifiers.\",\n      \"evidence\": \"Activity-based covalent chemical probe and mass spectrometry on the recombinant enzyme\",\n      \"pmids\": [\"17371404\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No endogenous substrates identified\", \"Relative preference for ubiquitin versus Nedd8 not quantified\", \"Cellular role not yet tested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mutagenesis of the active-site crossover loop resolved how the enzyme selects substrates, showing that steric restriction by the loop—not the catalytic machinery—limits which adducts can be cleaved.\",\n      \"evidence\": \"Sortagging, crossover-loop mutagenesis, and in vitro activity assays\",\n      \"pmids\": [\"19047059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequence of size restriction unknown\", \"Which native ubiquitin chain linkages are handled in vivo unclear\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystallographic capture of the enzyme with a suicide substrate provided the structural basis for both dual ubiquitin/Nedd8 specificity and substrate-size restriction, and genetic evidence established the gene as essential.\",\n      \"evidence\": \"X-ray structures (apo and UbVME complex), molecular dynamics of the enzyme–Nedd8 complex, and essentiality data\",\n      \"pmids\": [\"20042598\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental structure of the enzyme–Nedd8 complex\", \"Essentiality mechanism (which pathway failure kills the parasite) undefined\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Small-molecule inhibition linked the enzyme's catalytic activity to a cellular phenotype, showing that blocking it causes polyubiquitin accumulation and disrupts late asexual blood-stage parasites.\",\n      \"evidence\": \"In vitro enzyme inhibition with two compounds, anti-plasmodial growth assay, and immunofluorescence phenotyping\",\n      \"pmids\": [\"35042884\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Off-target contributions to the growth phenotype not excluded\", \"Specific accumulating substrates not identified\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Selective covalent fragments demonstrated that the enzyme's activity is required across life-cycle stages, extending its essentiality beyond blood stages to transmission-relevant sporozoites.\",\n      \"evidence\": \"Covalent fragment screen, selective enzyme inhibition over human orthologs, and growth assays in P. falciparum blood stages and P. berghei sporozoites\",\n      \"pmids\": [\"37634761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In-parasite target engagement not directly confirmed\", \"Stage-specific substrates unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}, {\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two orthogonal chemical-biology studies defined druggable surfaces beyond the catalytic site—an exosite at the ubiquitin substrate-binding interface and a halofuginone-binding pocket—clarifying how the enzyme can be inhibited allosterically.\",\n      \"evidence\": \"RaPID mRNA display peptides with NMR mapping and deubiquitinase assays [#5]; halofuginone photoaffinity chemoproteomics with docking and proteomics [#6]\",\n      \"pmids\": [\"38739798\", \"38923255\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Halofuginone binding modeled by docking, not high-resolution structure\", \"Direct causal link between the amino-acid metabolism proteome change and enzyme activity not established\", \"Physiological substrates whose deubiquitination is blocked remain unidentified\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The endogenous ubiquitin/Nedd8 substrates and the specific cellular pathway whose disruption makes the enzyme essential remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No physiological substrate identified\", \"Relationship between deubiquitinase and deNeddylase functions in vivo unresolved\", \"Interactome/complex membership uncharacterized\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004843\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0019784\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"GO:0016579\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0000338\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": [\n      \"Dual deubiquitinase/deNeddylase specificity is structurally explained by shared active-site interactions with ubiquitin and Nedd8 [#0, #2]\",\n      \"An active-site crossover loop imposes substrate-size restriction; enlarging it enables cleavage of otherwise-refractory substrates [#1]\",\n      \"Essential for parasite survival across asexual blood stages (P. falciparum) and sporozoite stages (P. berghei) [#2, #3, #4]\",\n      \"Inhibition causes accumulation of polyubiquitinated proteins in blood-stage parasites [#3]\",\n      \"Druggable via covalent fragments selective over human UCHL3/UCHL1 [#4], exosite-binding constrained peptides that block the ubiquitin substrate interface [#5], and direct halofuginone binding [#6]\"\n    ]\n  }\n}\n```","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1460400","name":null,"product":"ubiquitin carboxyl-terminal hydrolase isozyme L3","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1324100","name":null,"product":"ubiquitin carboxyl-terminal hydrolase isozyme L3, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1221300","name":null,"product":"ubiquitin carboxyl-terminal hydrolase isozyme L3, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"UCHL3","evaluation":null}